Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-19

Clinical Trial Update: Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Apatinib as neoadjuvant therapy for advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Colorectal Cancer, Neoadjuvant Therapy | Phase 2 | Status: UNKNOWN